Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation for loss of share certificate12-03-2021
12-03-2021
Sun Pharma share price rise over 2% after arm acquires stake in WRS Bioproducts
The share touched a 52-week high of Rs 653.70 and a 52-week low of Rs 315.20 on 12 February, 2021 and 23 March, 2020, respectively.10-03-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We refer to our disclosure, dated 5th March 2021, under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the agreement entered into by one of the wholly owned subsidiaries of the Company to acquire by way of allotment of 428,571 ordinary shares of WRS Bioproducts Pty Ltd. Further to the above, we wish to inform you that our above-referred subsidiary has acquired, on 10th March 2021,428,571 ordinary shares (equivalent to 12.5% fully diluted equity stake) of WRS Bioproducts Pty Ltd. by making the payment of AUD 2.0 Mn and complying with all requirements. This is for your information and dissemination.10-03-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We refer to our disclosure, dated 5th March 2021, under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the agreement entered into by one of the wholly owned subsidiaries of the Company to acquire by way of allotment of 428,571 ordinary shares of WRS Bioproducts Pty Ltd. Further to the above, we wish to inform you that our above-referred subsidiary has acquired, on 10th March 2021,428,571 ordinary shares (equivalent to 12.5% fully diluted equity stake) of WRS Bioproducts Pty Ltd. by making the payment of AUD 2.0 Mn and complying with all requirements. This is for your information and dissemination.10-03-2021
Growing specialty market share aids sentiment for Sun Pharma's stocks
Analysts say that even though competition and costs for specialty drugs are inevitable, market size is growing09-03-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation for issue of Duplicate Share Certificates05-03-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Acquisition
This is to inform you that one of the wholly owned subsidiaries of the Company has agreed to acquire by way of allotment to it, 428,571 ordinary shares (equivalent to 12.5% fully diluted equity stake) of WRS Bioproducts Pty Ltd, Australia, a company that is developing novel technologies to produce and commercialize supplements and nutraceutical ingredients from diverse algae species in Australia. The disclosures pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, are attached as per 'Annexure A'. This is for your information and record.05-03-2021
Quant Pick - Sun Pharmaceuticals: ICICI Direct
According to ICICI Direct, Buy Sun Pharmaceuticals in range of Rs 625-635 Target: Rs 738 Stop Loss: Rs 570 Time frame: Three months.05-03-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed Intimation for loss of Share certificates04-03-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 02, 2021 for Raksha Sudhir Valia02-03-2021